Semaglutide improves knee replacements for patients with diabetes
For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications. A team of Yale orthopedic surgeons found that taking semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, before a knee replacement can improve outcomes for these patients. Their findings were published in the Journal of Arthroplasty.
Source: Medical Xpress